Decline in hospitalization risk and health care cost after initiation of depot antipsychotics in the treatment of schizophrenia
Xiaomei Peng, Haya Ascher-Svanum, Douglas Faries, Robert R Conley, Kory J SchuhEli Lilly and Company, Indianapolis, IN, USAPurpose: To assess change in hospitalization and cost of care from 6 months pre- to 6 months post-initiation on any depot antipsychotic among schizophrenia patients.Patients and...
Saved in:
Main Authors: | Xiaomei Peng (Author), Haya Ascher-Svanum (Author), Douglas Faries et al (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2011-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness of early responders versus early nonresponders to atypical antipsychotic therapy
by: Peng X, et al.
Published: (2011) -
Predictors of antipsychotic monotherapy with olanzapine during a 1-year naturalistic study of schizophrenia patients in Japan
by: Ye W, et al.
Published: (2012) -
The personal, societal, and economic burden of schizophrenia in the People's Republic of China: implications for antipsychotic therapy
by: Montgomery W, et al.
Published: (2013) -
Hospitalization and cost after switching from atypical to typical antipsychotics in schizophrenia patients in Thailand
by: Boonlue T, et al.
Published: (2016) -
Reasons for initiating long-acting antipsychotics in psychiatric practice: findings from the STAR Network Depot Study
by: Corrado Barbui, et al.
Published: (2020)